This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)

Key Points Regencell Bioscience looks like a risky bet. It's generated zero revenue for several years in a row. Also, its valuation seems way out of line. 10 stocks we like better than Regencell Bioscience › Shares of Regencell Bioscience Holdings (NASDAQ: RGC) have been on quite a ride since their 2021 initial public offering (IPO), surging 9,800% year to date (as of Nov. 19). That's enough to drive many investors to buy. Why are they buying this growth stock? Some are simply hoping the shares ...